Public Announcement (NASDAQ: IXHL) (ASX : comparemela.com

Public Announcement





Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea

...

Related Keywords

Melbourne , Victoria , Australia , Chicago , Illinois , United States , Georgia , Texas , Australian , American , Joel Latham , Russell Rosenberg , John Douglas Hudson , Luke Medical Center , Incannex Healthcare Limited , Incannex Healthcare , Drug Administration , Incannex Healthcare Limited Nasdaq , Ohio State University , Australian Stock Exchange , Neurotrials Research In Atlanta , Edison Group , Continuous Positive Airway Pressure , Nasdaq , Public Announcement , Obstructive Sleep , Healthcare Limited , Investigational New Drug , Prescribing Information , Clinical Overviews , Study Reports , Key Literature References , Clinical Protocol , Investigator Information , Obstructive Sleep Apneoa , Apneoa Hypopnea Index , Rialto South Tower , Principal Investigators , Douglas Hudson , Principal Investigator , Futuresearch Trials , Chief Science Officer , Neurotrials Research , Rush Presbyterian , Medical Center , Incannex Board , American Depository Shares , Securities Litigation Reform Act , Chief Executive Officer , Relations Contact , Markets ,